Thus, we utilized flow cytometric analysis, using antibodies targeting EpCAM (tumor cells [16]) and CD45 (pan‐leukocyte marker [26]) to distinguish between tumor cells and immune cells within MPE samples. This evidence concerns the gene PTPRC and neoplasm.